Supplementary Table S2 from A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate CancerTanya Dorff,Lisa G. Horvath,Karen Autio,Alice Bernard-Tessier,Matthew B. Rettig,Jean-Pascal Machiels,Mehmet A. Bilen,Martijn P. Lolkema,Nabil Adra,Sylvie Rottey,Richard Greil,Nobuaki Matsubara,Daniel S.W. Tan,Alvin Wong,Hiroji Uemura,Charlotte Lemech,Johannes Meran, Youfei Yu,Mukul Minocha, Mason McComb,Hweixian Leong Penny,Vinita Gupta,Xuguang Hu, Gabor Jurida,Hosein Kouros-Mehr,Margit M. Janát-Amsbury,Tobias Eggert,Ben Trancrossref(2024)引用 0|浏览6暂无评分摘要Representativeness of study participants更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要